Aboriginal and Torres Strait Islander people aged 2 months to 19 years are recommended to receive a course of MenB vaccine.
MenB vaccine is funded through the NIP for all Aboriginal and Torres Strait Islander people aged <2 years at the time of their first dose. For details see the National Immunisation Program Schedule.
The dose schedule for MenB vaccine depends on the person’s age when they start the vaccine course.
For infants commencing vaccination at 2 months of age, MenB vaccine is recommended in a 3-dose schedule at 2, 4 and 12 months of age.
Aboriginal and Torres Strait Islander infants and children with specified medical risk conditions are recommended to receive an additional dose of MenB vaccine at 6 months of age, see People with medical conditions that increase their risk of invasive meningococcal disease.
Infants can have their 1st dose of MenB vaccine as early as 6 weeks of age. If the 1st dose of MenB vaccine is given at the age of 6 weeks, infants should still receive their next scheduled doses at 4 months and 12 months of age.
